Home therapy with autologous tumour-infiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma

被引：9
|
作者：
Tessier, MH
Pandolfino, MC
Jotereau, F
Boudart, D
Litoux, P
Dreno, B
机构：
[1] CHU NANTES,HOTEL DIEU,DEPT DERMATOL,F-44035 NANTES 01,FRANCE
[2] INSERM,U211,F-44035 NANTES 01,FRANCE
[3] CTR REG TRANSFUS SANGUINE,BLOOD BANK,F-44035 NANTES 01,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1996年 / 32A卷 / 04期
关键词：
D O I：
10.1016/0959-8049(95)00651-6
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：735 / 736
页数：2
相关论文
共 50 条
  • [41] Clinical feasibility and treatment outcomes with unselected autologous tumour-infiltrating lymphocyte (TIL) therapy in patients with advanced cutaneous melanoma
    Hawkins, R. E.
    Jiang, Y.
    Lorigan, P. C.
    Thistlethwaite, F. C.
    Pillai, M.
    Thomas, M.
    Kirillova, N.
    Bridgeman, J. S.
    Kueberuwa, G.
    Guest, R. D.
    Roberts, Z. J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A7 - A8
  • [42] IMMUNOTHERAPY OF METASTATIC MELANOMA WITH INTERLEUKIN-2
    PACIUCCI, PA
    MOUNT SINAI JOURNAL OF MEDICINE, 1992, 59 (03): : 238 - 243
  • [43] TREATMENT OF METASTATIC MELANOMA WITH INTERLEUKIN-2
    CHOSIDOW, O
    GUILLAUME, JC
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1992, 119 (01): : 65 - 73
  • [44] Dendritic cell density and activation status of tumour-infiltrating lymphocytes in metastatic human melanoma: possible implications for sentinel node metastases
    Barbour, AH
    Coventry, BJ
    MELANOMA RESEARCH, 2003, 13 (03) : 263 - 269
  • [45] TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN MELANOMAS
    SONDEL, PM
    SOSMAN, JA
    HANK, JA
    KOHLER, PC
    STORER, B
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (21): : 1418 - 1419
  • [46] Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2
    Heemskerk, Bianca
    Liu, Ke
    Dudley, Mark. E.
    Johnson, Laura A.
    Kaiser, Andrew
    Downey, Stephanie
    Zheng, Zhili
    Shelton, Thomas E.
    Matsuda, Kant
    Robbins, Paul F.
    Morgan, Richard A.
    Rosenberg, Steven A.
    HUMAN GENE THERAPY, 2008, 19 (05) : 496 - 510
  • [47] Mast cell density in metastatic renal cell carcinoma: Association with prognosis and tumour-infiltrating lymphocytes
    Yao, Jiaxi
    Xi, Wei
    Chen, Xiang
    Xiong, Ying
    Zhu, Yanjun
    Wang, Hang
    Hu, Xiaoyi
    Guo, Jianming
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2021, 93 (04)
  • [48] Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma
    Eton, O
    Rosenblum, MG
    Legha, SS
    Zhang, WH
    East, MJ
    Bedikian, A
    Papadopoulos, N
    Buzaid, A
    Benjamin, RS
    CANCER, 2002, 95 (01) : 127 - 134
  • [49] Tumor-infiltrating lymphocytes and interleukin-2: Dose and schedules of administration in the treatment of metastatic cancer
    Dillman, R
    Schiltz, P
    DePriest, C
    Barth, N
    Beutel, L
    de Leon, C
    O'Connor, A
    Nayak, S
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2004, 19 (06) : 730 - 737
  • [50] Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: Removal of tumour cells does not affect tumour-specificity
    Mulder, WMC
    Stukart, MJ
    Roos, M
    vanLier, AW
    Wagstaff, J
    Scheper, RJ
    Bloemena, E
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995, 41 (05) : 293 - 301
12345